Delivery of medicinal products for programs and chemotherapy at USK-2 PUM in Szczecin
We are seeking suppliers for medicinal products used in treatment programs and for cancer chemotherapy for the clinics of USK-2 PUM in Szczecin. The delivery includes a wide range of pharmaceuticals compliant with legal regulations.
CONTRACTING AUTHORITY
Name
UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE
City
Szczecin
Country
PL
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33690000, Various medicinal products.
Other CPV
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
33662100, Ophthalmologicals.
33652100, Antineoplastic agents.
33642300, Thyroid therapy medicinal products.
33622200, Antihypertensives.
33622100, Cardiac therapy medicinal products.
33640000, Medicinal products for the genitourinary system and hormones.
33610000, Medicinal products for the alimentary tract and metabolism.
LOTS (15)
Medikamente für das Augen-Uveitis-Programm B.105
PLN 61,056
Medikamente für das Programm zur Behandlung von Blasenkrebs B.141.FM
€898,456
Medikamente für die Chemotherapie von Krebserkrankungen
€1,701,389
Medikamente für das Programm zur Behandlung von sekundärer Hyperparathyreose B.39
€216,240
Medikamente für das Programm zur Behandlung von Prostatakrebs B.56
€3,719,454
Medikamente für das Programm zur Behandlung von pulmonaler arterieller Hypertonie B.31
€2,269,703
Medikamente für das Programm zur Behandlung von Kardiomyopathie B.162
€2,604,420
Medikamente für das Programm zur Behandlung von Blasenkrebs B.141.FM
€4,514,789
Medikamente für die Krebstherapieprogramme B.4; B.10; B.159
€2,764,370
Medikamente für das Programm bei neurogener Detrusorüberaktivität B.73
€29,627
Medikamente für das Programm zur Behandlung von pulmonaler arterieller Hypertonie B.31
€8,997,492
Medikamente für die Chemotherapie von Krebserkrankungen
€939,421
Medikamente für die Chemotherapie von Krebserkrankungen C.104
€82,226
Medikamente zur Unterstützung der Chemotherapie - Antiemetika
€81,407
Medikamente zur Unterstützung der Chemotherapie - Hämatopoetika C.0.10.
€445,200
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
29 days remaining(LOT-0001)
Published